Class Actions Filed Against PROCEPT Over Alleged Sales Discounting and Inventory Glut

Overview

• Multiple plaintiff firms have filed securities class action complaints accusing PROCEPT BioRobotics of misleading investors about U.S. handpiece sales during the period February 28, 2024 to February 25, 2026.
• The complaints allege the company used extensive discount programs to pull orders forward, which plaintiffs say artificially boosted reported unit sales and revenues.
• One plaintiff notice claims the discounting created a field inventory surplus of more than 10,000 excess handpiece units by the end of the class period, a figure the firms say shows weak end‑user demand.
• Plaintiffs further contend PROCEPT’s public statements overstated system utilization and left investors exposed to undisclosed operational and financial risks, including that 2025 sales guidance lacked a sound factual basis.
• Shareholders are being solicited to join the suits and to seek lead‑plaintiff status with motions due by September 22, 2026, and no class certification or court ruling on the merits has been reported yet.